Showing results (211-220 of 286) with videos related to
Sort By:
Pageof 29
The Journal of Pediatrics|August 31, 2024
Mitigating Alarm Fatigue and Improving the Bedside Experience by Reducing Nonactionable AlarmsJeffrey K Yang, Felice Su, Anna Graber-Naidich, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: clinical and pharmacologic factors affecting outcomeBrigitte C Widemann, Frank M Balis, AeRang Kim, et al.Clinical Pharmacology and Therapeutics|June 14, 2023
Model-Informed Precision Dosing Guidance of Ethosuximide Developed from a Randomized Controlled Clinical Trial of Childhood Absence EpilepsyKana Mizuno, Edmund V Capparelli, Tsuyoshi Fukuda, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2012
A phase I trial and pharmacokinetic study of aflibercept (VEGF Trap) in children with refractory solid tumors: a children's oncology group phase I consortium reportJulia Glade Bender, Susan M Blaney, Scott Borinstein, et al.Neurology|May 31, 2013
Pretreatment EEG in childhood absence epilepsy: associations with attention and treatment outcomeDennis Dlugos, Shlomo Shinnar, Avital Cnaan, et al.Antimicrobial Agents and Chemotherapy|December 31, 2008
Pharmacokinetics and safety of caspofungin in older infants and toddlersMichael Neely, Hasan S Jafri, Nita Seibel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2007
Phase I trial and pharmacokinetic study of pemetrexed in children with refractory solid tumors: the Children's Oncology GroupSuman Malempati, H Stacy Nicholson, Joel M Reid, et al.Pediatric Blood & Cancer|June 20, 2020
Pediatric cancer research: Surviving COVID-19Jeffery J Auletta, Peter C Adamson, Jonathan E Agin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2007
Phase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent leukemia: a Children's Oncology Group StudyTerzah M Horton, Patrick A Thompson, Stacey L Berg, et al.Critical Care (London, England)|May 7, 2022
Machine learning derivation of four computable 24-h pediatric sepsis phenotypes to facilitate enrollment in early personalized anti-inflammatory clinical trialsYidi Qin, Kate F Kernan, Zhenjiang Fan, et al.Pageof 29